KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Return on Assets: 2012-2024

Historic Return on Assets for Supernus Pharmaceuticals (SUPN) over the last 13 years, with Dec 2024 value amounting to 0.06%.

  • Supernus Pharmaceuticals' Return on Assets fell 6.00% to -0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.01%, marking a year-over-year decrease of 6.00%. This contributed to the annual value of 0.06% for FY2024, which is 5.00% up from last year.
  • Latest data reveals that Supernus Pharmaceuticals reported Return on Assets of 0.06% as of FY2024, which was up 6,222.33% from 0.00% recorded in FY2023.
  • In the past 5 years, Supernus Pharmaceuticals' Return on Assets registered a high of 0.10% during FY2020, and its lowest value of 0.00% during FY2023.
  • Moreover, its 3-year median value for Return on Assets was 0.04% (2022), whereas its average is 0.03%.
  • Per our database at Business Quant, Supernus Pharmaceuticals' Return on Assets decreased by 6bps in 2021 and then climbed by 5bps in 2024.
  • Yearly analysis of 5 years shows Supernus Pharmaceuticals' Return on Assets stood at 0.10% in 2020, then decreased by 6bps to 0.03% in 2021, then remained steady at 0.04% in 2022, then dropped by 3bps to 0.00% in 2023, then rose by 5bps to 0.06% in 2024.